These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 38677505

  • 1. LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1.
    Cai Y, Liu Y, Sun Y, Ren Y.
    Arch Biochem Biophys; 2024 Jun; 756():110018. PubMed ID: 38677505
    [Abstract] [Full Text] [Related]

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 3. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y, Zhang L, Chen X, Chen S, Shi Y, Li J.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31072914
    [Abstract] [Full Text] [Related]

  • 4. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J, Dai C, Yu X, Yin XB, Zhou F.
    Cell Cycle; 2020 Apr 28; 19(8):870-883. PubMed ID: 32178558
    [Abstract] [Full Text] [Related]

  • 5. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.
    Chen H, Hou G, Yang J, Chen W, Guo L, Mao Q, Ge J, Zhang X.
    J Cell Mol Med; 2020 Jun 28; 24(11):6070-6082. PubMed ID: 32329150
    [Abstract] [Full Text] [Related]

  • 6. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.
    Yao J, Yang Z, Yang J, Wang ZG, Zhang ZY.
    Aging (Albany NY); 2021 May 23; 13(10):13726-13738. PubMed ID: 34023817
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY, Sun QC, Zou XJ, Song Y, Li WW, Guo ZQ, Liu SS, Liu L, Wu DH.
    J Exp Clin Cancer Res; 2020 Oct 29; 39(1):229. PubMed ID: 33121524
    [Abstract] [Full Text] [Related]

  • 11. Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
    Xie Y, Wang F, Yu J, Zhang J, Liu Y, Li M, Qi J.
    Oncol Rep; 2021 Dec 29; 46(6):. PubMed ID: 34617573
    [Abstract] [Full Text] [Related]

  • 12. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S, Xue H, Li Y, Li P, Ma F, Liu M, Li W.
    Exp Cell Res; 2020 Oct 01; 395(1):112180. PubMed ID: 32682012
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J, Han X, Qi X, Jin X, Li X.
    Int J Oncol; 2017 Oct 01; 51(4):1115-1123. PubMed ID: 28902349
    [Abstract] [Full Text] [Related]

  • 17. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y, Dun Y, Zhou S, Huang XH.
    Biomed Pharmacother; 2017 Dec 01; 96():1216-1221. PubMed ID: 29239819
    [Abstract] [Full Text] [Related]

  • 18. MTF2 facilitates the advancement of osteosarcoma through mediating EZH2/SFRP1/Wnt signaling.
    Hu X, Liu Y, Shen H, Zhang T, Liang T.
    J Orthop Surg Res; 2024 Aug 08; 19(1):467. PubMed ID: 39118123
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p/Notch1 axis.
    Mao X, Ji T, Liu A, Weng Y.
    Cell Death Dis; 2021 Oct 18; 12(11):957. PubMed ID: 34663788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.